Control lots may not meet stability criteria and could result in increased results of patient samples for cortisone.
Source facts
Action
The firm sent consignees a recall notification letter dated 10/28/2020. Consignees are asked to stop using products and to destroy remaining stock of affected product in accordance with the consignees laboratory procedures. The recalling firm will replace affected stock with new lots.
Consignees are asked to further disseminate recall information to any other customers that the product has been shipped to.
A response form is included with the recall notification letter and customers are asked to complete the form and return to the recalling firm.
Initiated
2020-10-29
Root cause
Under Investigation by firm
Distribution
US Nationwide distribution in the states of NC and NY.
Recall number
Z-0523-2021
Recall status
Completed
CDRH record ID
184337
FDA record created
2020-12-02
Recall event number
86699
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.